caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1841481025

Ulka DesaiM.D.

NephrologyHouston, TXI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Ulka Desai's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 115 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Houston, TX
111488
Faisal Arain
Cardiology · Houston, TX
55226
Sanjay Kunapuli
Interventional Cardiology · Houston, TX
50761
Kapil Shroff
Diagnostic Radiology · Houston, TX
50202
Quynh Lam
Nephrology · Houston, TX
48293
Fayaz Faiz
Neurology · Houston, TX
48358
Tulsidas Kuruvanka
Cardiology · Houston, TX
47338
NPI 125533553546172
John Haddad
Diagnostic Radiology · Houston, TX
44212
David Light
Diagnostic Radiology · Houston, TX
41237
NEW MEDICAL HORIZONS II, LTD.41158
Jamil Mohsin
Cardiology · Tomball, TX
39272
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,173
Unique beneficiaries
—
Total services
3,062
Distinct HCPCS
12
Medicare payment
$266K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 883 Nephrology providers in TX — top quintile (cohort median 1,432).
PRESCRIBING · PART D · 2024
Total Rx claims
1,324
Beneficiaries
—
Total drug cost
$384K
Distinct drugs
39
Brand share
22.1%
Top prescribed drugs
Furosemide119 claims
Allopurinol104 claims
Losartan Potassium90 claims
Dapagliflozin Propanediol86 claims
Nifedipine63 claims
QUALITY · MIPS · 2024
Final MIPS score
92.5
Quality
85.3
Cost
71.3
Improvement activities
40.0
Promoting interop.
98.0
Payment adjustment
0.74%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$599
Payment records
31
By payment type
Food and Beverage$599
Top paying entities
Food and Beverage$599